|
|
:
Glaucoma-Tests:
-
Tonometry
measures intraocular pressure (IOP) in millimeters of mercury
(mm Hg). IOP can be measured non-invasively at home with the Proview
home eye pressure monitor, which is as accurate as Goldmann tonometry
(the gold standard), yet without anesthetic or risk of injury
to the cornea.
-
Serial tonometry
can be used to plot a diurnal curve, with glaucoma patients showing
greater daily changes in pressure. This can now be done at home
with the Proview.
-
Tonography
continuously measures IOP changes over several minutes in response
to a slight pressure stimulus to increase the outflow of aqueous
humor from the eye. This can be done at home with the Proview
and shiatsu or other eye massage techniques as well as extended
to a biofeedback for color therapy, drinking microwater, eye-stretch,
rebounding and other remedies to monitor effectiveness at lowering
IOP.
-
Provocative tests
can involve water loading, dark adaptation or pupil dilation to
check for elevation of IOP with these probes. These can be done
at home with the Proview, but it is
not recommended to drink more water than your body can absorb
into the tissues and lymph. You can drown from drinking too much
water too fast, as the lungs fill up with fluid. 4 ounces every
half hour is best throughout the daylight hours, and now you can
monitor the effects of your drinking habits on IOP with the Proview.
-
Stereo disc photography
monitors 3-D changes in structure of the optic nerve head and
its blood vessels. This can also be scanned by laser.
-
Gonioscopy
views the drainage angle of the anterior chamber of the eye. The
drainage angle can also be visualized by high resolution ultrasound.
-
Ophthalmoscopy
provides a high magnification view of the optic nerve head.
-
Peripheral Vision
(fields) testing: achromatic automated perimetry (AAP) only begins
to show field loss when about half of the nerve fibers are lost.
Earlier detection is found with color (especially Blue) fields,
such as Short-Wavelength Automated Perimetry (SWAP), as well as
Frequency-Doubling Perimetry (FDP).
Landers JA, Goldberg I, Graham SL. Detection of
early visual field loss in glaucoma using frequency-doubling perimetry
and short-wavelength automated perimetry. Arch Ophthalmol 2003;121(12):1705-10.
-
Color Doppler Imaging
(CDI): Patients with stable visual fields had higher diastolic
velocity and a lower resistivity index in the ophthalmic artery
compared with those with deteriorating fields during a 7 year
study. The odds of visual field deterioration in patients with
an ophthalmic artery resistivity index of 0.78 or higher is about
6 times that for resistivity index < 0.78 in primary open-angle
glaucoma.
Galassi F, Sodi A, Ucci F, et al. Ocular
hemodynamics and glaucoma prognosis: a color Doppler imaging study.
Arch Ophthalmol 2003;121(12):1711-5.
References:
(see print version for text location of
these footnotes)
Sardi B. Nutrition and the Eyes, Vol. III.
Montclair, California: HealthSpectrum Publishers, 1994, p. 48.
Caputo BJ, Katz LJ. The quality of life of the glaucoma patient
in the light of treatment modalities, Current Opinion in Ophthalmology
5, II:10-14, 1994.
Guzman G, et al. Glaucoma in the United States population: the economic
burden of illness. Investigative Ophthalmology 1992; 33: ARVO Abstracts
327.
Lee P. Economic concerns in glaucoma management in the 21st Century.
Journal of Glaucoma 2:148-51, 1993.
Leydhecker W, Krieglestein GK. Glaucoma Update II. Springer-Verlag,
Berlin, 95-102, 1983.
Wright M. Testing, coverage must improve to make progress in glaucoma.
Ophthalmology Times, p 18, June 15, 1993.
Mikelberg F.S., et al, “Optic nerve axon count and anxon diameter
in patients with ocular hypertension and normal visual fields, Opthalmology
1995, 102:342-48.
Stocker F.W., New ways of influencing the intraocular pressure,
New York State Medical Journal 1949; 49:58-63.
Leydhecker W, Krieglestein GK. Glaucoma Update II. Springer-Verlag,
Berlin, 95-102, 1983.
Morrill K., Study examines link between IOP and field loss, Ocular
Surgery News, Fevruary 1, 1192, p.32.
Veriac S., Tissie G., Bonne C., Alterations of energetic metabolite
levels by free radicals during optic nerve ischemia, Current Eye
Research 1992; 11: 275-78.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Melby C.L., Toohey M.L., Cebrick J., Bllod pressure and blood lipids
among vegetarian, semivegitarian and nonvegetarian African Americans,
American Journal Clinical Nutrition1994; 59:103-09.
Simon H.B., Patient-directed, nonprescription approaches to cardiovascular
disease, Archives of Idicine 1994; 154:2283-2296.
Dorigo M. T., Altafini R., Aging and drug-induced optic nerve side
effects, Metabolic, Pediatric and Systemic Opthalmology 1989; 12:24-27.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.18-20.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.22.
Tengroth B, Ammitzboll T. Changes in the content and composition
of collagen in the glaucomatous eye - Basis for a new hypothesis
for the genesis of chronic open-angle glaucoma. Acta Ophthalmologica
62:999-1008, 1984.
Quigley H, Addicks E. Regional differences in the structure of the
lamina cribrosa and their relation to glaucomatous optic nerve damage.
Arch Ophthalmol 99:137-43, 1983.
Krakau T, et al. The glaucoma theory updated. Acta Ophthalmol 61:737-41,
1983.
Rohen J. Why is intraocular pressure elevated in chronic simple
glaucoma? Ophthalmology 90:758-65, 1983.
Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Vol. I.
Seattle: John Bastyr College Publications, 1987.
Kelly T S-B. Myopia or expansion glaucoma, in Documenta Ophthalmologica
Proceedings Series. Vol. 28. Third International Conference on Myopia,
Copenhagen, ed. HC Fledelius, PH Alsbirk and E Goldschmidt, The
Hague: Dr. W Junk Publisher, 1981, 109-16.
Weiss J, Jayson M. Collagen in Health and Disease. p388-403, Churchill
Livingston, New York, 1982.
Stewart W.C., Reid K.K, Incidence of systemic and ocular disease
that may mimic low-tension glaucoma, Journal of Glaucoma 1992; 1:27-31.
Schulzer M., et al, Biostatistical evidence for two distinct chronic
open angle glaucoma populations, British Journal of Opthalmology
1990; 74:196-200.
Sugiyama D.T., et al, Support for the vasogenic theory of glaucoma:
case reports and literature review, Journal American Optometric
Association 1993; 64:568-82.
Michelson, E.L., et al, Retinal arteriolar changes as an indicator
of coronary artery diseae, Archives of Internal Medicine 1979; 139:1139-41.
Perasalo R., Raitta C., Perasalo J., Optic nerve fiber loss in relation
to atrial fibrillation and blood pressure, International Opthalmology
1992; 16: 259-63.
Jonas J.B., et al, Parapapillary retinal vessel diameter in normal
and glaucoma eyes, Investigative Opthalmology 1989; 30: 1599-1603,
1989.
Cennamo G., Caruso C., Rocco P., Thermographic study in glaucoma,
Glaucoma 1985; 7: 84-87.
Gutman I, et al, Optic nerve compression by carotid arteries in
low-tension glaucoma, Graef’s Archive Opthalmology 1993; 231:711-17.
Stroman G.A. et al, Magnetic resonance imaging in patients with
low-tension glaucoma, Archives of Opthalmology 1995; 113:168-72.
Hoyng P.F.J., et al, Platelet aggregation and glaucoma, Documenta
Opthalmologica 1985; 61:167-73.
Klaver J.H.J., Greve E.L., Goslinga H., Geijssen H.C., Heuvelmans
J.H.A., Blood plasma viscosity measurements in patients with glaucoma,
British Journal of Opthalmology 1985; 69:765-70.
Gasser P., Flammer J., Blood-cell velocity in the nailfold capillaries
of patients with normal-tension and high-tension glaucoma, American
Jouranal of Opthalmology 1991; 111:585-88.
Corbett J.J. et al, The neurologic evaluation of patients with low-tension
glaucoma, Investigative Opthalmology 1985; 26:1101-1104.
phelps C.D., Corbett J.J., Migraine and low-tension glaucoma, Investigative
Opthalmology 1985; 26:1105-08.
Kaiser H.J., Glammer J., Burckhardt D., Silent myocardial ischemia
in glaucoma patients, Opthalmologica 1993; 207:6-8.
Davis M.A., Fogt N.F., Ocular ischemic syndorme iris neovascularization,
and primary open angle glaucoma in a patient with carotid stenosis,
Southern Journal of Optometry, 1994; 12:13-18.
James C.B., Intraocular pressure in carotid artery disease, Neuro-opthalmology
1992; 12:279-84.
Foulds W.S., Blood is thicker than water, Eye 1987; 1:343-63.
Trope G.E., Salinas R.G., Glynn M., Blood viscosity in primary open-angle
glaucoma Canadian Journal Opthalmology 1987; 22:202-04.
Schulzer M, et al. A comparison of treated and untreated glaucoma
suspects. Ophthalmology 98:301-7, 1991.
Weighing the evidence for glaucoma treatment. Ocular Surgery News,
p 33-37, July 15, 1988.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 60.
Celermajer D.S., et al, Cigaretter smoking is associated with dose-related
and potentially reversible impairment of endothelium-dependent dilation
in healthy your adults, Circulation 1993; 88:2149-55.
Carenini B.B., et al, Ischaemia and glaucoma, New Trends in Opthalmology
1993; 2:75-80.
Jay FL, et al. Early trabeculectomy versus conventional management
in primary open-angle glaucoma. British Journal of Ophthalmology
72:881-9, 1988.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 60.
Harding J.J., Egerton M., Risk factors for cataract in Oxfordshire:
diabetes, peripheral neuroptahy, myopia, glaucoma and diarrhoea,
Acta Opthalmologica 1989; 65:790-95.
Wright M. What are the reasons for patient non-compliance? Ophthalmology
Times p 20, June 1, 1990.
Rizzo J.F., Lessell S., Tobacco amblyopia, American Journal of Opthalmology
1193; 116:84-87.
Gurwitz JH, et al. Treatment for glaucoma: adherence by the elderly.
American Journal of Public Health 83:711-6, 1993.
Caputo BJ, Katz LJ. The quality of life of the glaucoma patient
in the light of treatment modalities, Current Opinion in Ophthalmology
5, II:10-14, 1994.
Sardi B. Glaucoma - Part 1. Is the treatment worse than the disease?
Townsend Letter for Doctors and Patients 148: 64-68, 1995.
Study reported in: Caputo BJ, Katz LJ. The quality of life of the
glaucoma patient in the light of treatment modalities, Current Opinion
in Ophthalmology 5, II:10-14, 1994.
Caputo BJ, Katz LJ. The quality of life of the glaucoma patient
in the light of treatment modalities, Current Opinion in Ophthalmology
5, II:10-14, 1994.
Reiss G.R., et al, Ascorbic acid levels in aqueous humor of nocturnal
and diurnal mammals, Archives of Opthalmology 1986; 104:753-55.
Schulzer M. Errors in the diagnosis of visual field progression
in normal-tension glaucoma. Ophthalmology 101:1589-95, 1994.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Tengroth B, Ammitzboll T. Changes in the content and composition
of collagen in the glaucomatous eye - Basis for a new hypothesis
for the genesis of chronic open-angle glaucoma. Acta Ophthalmologica
62:999-1008, 1984.
Ponte F, et al. Risk factors of ocular hypertension and glaucoma.
Documenta Ophthalmologica 85:203-10, 1994.
Skalka H.W., Prchal J.T., Effect of corticosteroids on cataract
formation, Archives of Opthalmology 1980;98:1773-77.
Francois J., Corticosteroid glucoma, Metabolic Opthalmology 1978;2:3-11.
Mohan R. Muraldharan A.R., Steroid induced glaucoma and cataract,
Indian Journal of Opthalmology 1989; 37:13-16.
Opatowdky I., et al, Itnraocular pressure elevationassociated with
inhalation and nasal corticosteroids, Opthalmology 1995; 102:177-79.
Bloom E., Effects of oxidative injury on phagocytosis in human trabecular
meshwork (HTM) cells, Investigative Opthalmology 1990; 31; ARVO
Abstracts March 15.
list available from Remission Foundation.
Leopold I.H., Drug-induced optic atrophy, Principles and Practice
of Opthalmology, Albert and Jakobiec, W.B. Saunders, Philadelphia
1994, pp 525-26.
Dorigo M.T., Altafini R, Aging and drug-induced optic nerve side
effects, Metabolic, Pediatric and Sytemic Opthalmology 1989; 12:24-27.
Jong de C, et al. Topical timolol with and without benzalkonium
chloride. Graefe’s Archives of Clinical Ophthalmology, 232:221-4,
1994.
see: Physician’s Desk Reference (PDR).
Gobbels M, Spitznas M. Effects of artificial tears on corneal epithelial
permeability in dry eyes. Graefe’s Archives of Ophthalmology
229:345-9, 1991.
Lemp MA, Zimmerman LE. Toxic endothelial degeneration in ocular
surface disease treated with topical medications containing benzalkonium
chloride. American Journal of Ophthalmology 105:670-3, 1988.
Chapman JM, et al. Interactions of benzalkonium chloride with soft
and hard contact lenses. Archives of Ophthalmology 108:244-6, 1990.
Leske M.C., The epidemiology of open-angle glaucoma: a review, American
Journal of Opthalmology 1983; 118:166-91.
Gramer E., Althaus G., Korner U., Are visual field defects in the
lower hemifield a risk factor in POAG?, In Perimetry Update, Proceedings
of the Xth International Perimetirc Society Meeting, Kyoto, Edited
by R.P. Mills, New York, Kugler 1993; 81-87.
Virno M., et al, Oral treatment of glaucoma with vitamin C, The
Eye Ear Nose & Throat Monthly 1967; 46: 1502-08.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.19.
Leopold I.H., Drug-induced optic atrophy, Principles and Practice
of Opthalmology, Albert and Jakobiec, W.B. Saunders, Philadelphia
1994, pp 525-26.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.17.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Schoenberg M.J., The artificial induction of ocular hypertension
by compression of the jugular veins, Archives of Opthalmology 1929;1:681-91.
Regualr of decaf? Coffee consumption and serum lipoproteins, Nutrition
Reviews 1992; 50: 175-78.
van Dusseldorp M., et al, Cholesterol-raising factor from boiled
coffee does not pass a paper filter, Ateriosclerosis and Thrombosis,
1991; 11:586-93.
Adams B.A., Brubaker R.F., Caffeine has no clinically significant
effect on aqueous humor flow in the normal human human eye, Opthalmology
1990;97:1030-1.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.34.
Wilson R.M., et al, A case-control study of risk factors in open
angle glaucoma, Archives of Opthalmology 1987; 105:1066-71.
Carper J., Food Your Miracle Medicine, Harper Collins 1993.
Moliterno D.J., et al, Coronary-artery vasoconstriction induced
by cocaine, cigarette smoking, or both, New England Journal of Medicine
1994; 330: 454-49.
Celermajer D.S., et al, Cigarette smiking is associated with dose-related
and potentially reversible impairment of endothelium-dependent dialtion
in healthy young adults, Circulation 1993; 88:2149-55.
Mehra K.S., Roy P.N., Khare B.B., Tobacco smoking and glaucoma,
Annals of Opthalmology 1976; 8:462-64.
Rizzo J.F., Lessell S., Tobacco amblyopia, American Journal of Opthalmology
1193; 116:84-87.
Leishman R., Gastric function in tobacco amblyopia, Transactions
Opthalmolgical Society
Rizzo J.F., Lessell S., Tobacco amblyopia, American Jouranl of Opthalmology
1193; 116:84-87
Morgada P.B., et al, The acute effect of smoking on retinal blood
flow in subjects with and without diabetes, Opthalmology 1994; 101:1220-26.
Costagliola C., et al, Red cell reduced glutathione and tobacco
smoke-induced optic neuropathy, Metabolic, Pediatric and Systemic
Opthalmology 1990;13:96-98.
Golnik K.C., Schaible E.R., Folate-responsive optic neuropathy,
Journal of Neuro- Opthalmology
Leopold I.H., Drug-induced optic atrophy, Principles and Practice
of Opthalmology, Albert and Jakobiec, W.B. Saunders, Philadelphia
1994, pp 525-26.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients. 46-51, Dec. 1995.
Carper J., Food Your Miracle Medicine, Harper Collins 1993.
Merati G., et al, Antioxidant activity of ubiquinone-3 in human
low density lipoprotein, Free Radical Research Communications 1992;
16:11-17.
Anderson T.J., et al, The effect of cholesterol-lowering and antioxidant
therapy on endothelium-dependent coronary vasomotion, New England
Journal of Medicine 1995; 332:488-93.
Sardi B. Glaucoma: Underlying Factors, Part 3. Townsend Letter for
Doctors & Patients, Jan. 1996, 52-65.
Haefliger I.O., Meyer P., Glammer J., Luscher T.F., The vascular
endothelium as a regulator of the ocular circulation: a new concept
in opthalmology? Survey of Opthalmology 1994; 39:123-32.
Wilson R.M., et al, A case-control study of risk factors in open
angle glaucoma, Archives of Opthalmology 1987;105: 1066-71.
Martin B.J., et al, Exercise training reduces intraocular pressure
among subjects suspected of having glaucoma, Archives of Opthalmology
1991; 109: 1096-98.
Marshall E.C., Radial differences in the presentation of chronic
open-angle glaucoma, Journal American Optometric Association 1989;
60:760-67.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.22.
Teikair J.M., Kaprio J., Koskenvuo M., Pseudoexfoliation of the
lens capsule in six twin pairs, Glaucoma 1990; 12: 183-89.
Linner E., The assoicaiton of ocular hypertension with the exfoliation
syndrome, the pigmentary dispersion syndrome and myopia, Survey
of Opthalmology 1980; 25:145-47.
Hietanen J., et al, Exfoliation syndrome in patients scheduled for
cataract surgery, Acta Opthalmologica 1992;70:440-46.
Squires S., New study finds recrod 1 in 3 Americans seriously overweight,
Los Angeles Ti mes, July 20, 1994.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Moliterno D.J., et al, Coronary-artery vasoconstriction induced
by cocaine, cigarette smoking or both, New England Journal of Medicine
1994; 330:454-49.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.22.
Merati, G, et al, Antioxidant activity of ubiquinone-3 in human
low density lipoprotein, Free Radical Resarch Communications 1992;
16:11-17.
Cartwrighj M.J., et al, Immune-related disease and normal-tension
glaucoma: A case control study, Archives of Opthalmology 1992; 110:500-02.
Migdal C, et al. Long-term functional outcome after early surgery
compared with laser and medicine in open-angle glaucoma. Ophthalmology
101:1651-7, 1994.
Golnik K.C., Schaible E.R., Folate-responsive optic neuropathy,
Journal of Neruo- Opthalmology1994; 14:163-69.
James C.B., Effect of trabeculectomy on pulsatile ocular blood flow,
British Journal of Opthalmology 1994;78:818-22.
Henaham J.F., Surgery improves low-tension glaucoma, but disease
goes on, Opthalmology Times, 1992; August 15, p.10.
Spaeth GL, Birbilis EP. The effect of glaucoma and treatment of
glaucoma on the quality of life. Glaucoma Update IV, Springer-Verlag,
Berlin, p 206-7, 1991.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.32.
Passo M.S., et al, Regular exercise lowers introcular pressure in
glaucoma patients, Investigative Opthalmology 1994; 35: Arvo Abrstarcts
March 15.
Stewart W.C., Crinkley C.M.C., Murrell H.P., Cigarette-smoking in
normal subjects, ocular hyupertensive, and chronic open-angle glaucoma
patients, American Journal of Opthalmology 1994; 117:267-68.
Shepard R.J., et al, Effects of cigarette smoking on intraocular
pressure and vision, Brithish Journal of Opthalmology 1978; 62:682-87.
Asregadoo E.R., Blood levels of thiamine and ascorbic acid in chronic
open-angle glaucoma, Annals of Opthalmology 1979; 11:1095-1100.
Melamed S., deKater A.w., Glaucoma after recurrent herpes simplex
keratouveitis: a cinicopathologic study, Glaucoma 1991;13:40-43.
Babizhayev M.A., Bunin A.Y., Lipid peroxidation in open-angle glaucoma,
Opthalmologica 1989;67:371-77.
Virno M., et al, “Aqueous humor alkalosis and marked reductionin
ocular ascorbic acid content following long-term topical cortisone,”
Annals of Opthalmology, 1974; 6:983-92.
Feldman R.M., Steinmann W.C., Spaeth G.L., Varma R., Effects of
altered daily fluid intake on intraocular pressure in glaucoma patients,
Glaucoma 1987; 9:118-21.
Buckingham T., Yourng R., The rise and fall of intra-ocular pressure:
the influence of physiological factors, Opthalmology Physiological
Optics 1986; 6:95-99.
Feldman R.M., Steinman W.C., Spaeth G.L., Varma R., Effects of altered
daily fluid intake on on intraocular pressure in glaucoma patients,
Glaucoma 1987; 9:118-21.
Bunce G.E., Nutrition and the eye disease of the elderly, Journal
Nutritional Biochemsitry 1994; 5:66-77.
Lichter P.R., Caffeine and other prescriptions for patients with
flaucoma, Opthalmology 1990; 97:965-66.
University of California at Berkeley Wellness Letter, 1994;10:1-4.
Morgada P.B., et al, The acute effect of smoking on retinal blood
flow in subjects with and without diabetes, Opthalmology 1994; 101:
1220-26.
Batmanghelidj F. Your Body’s Many Cries for Water. Falls Church,
Virginia: Global Health Solutions, Inc., 1995.
Gasser P., Ocular vasospasm: a risk factor in the pathogenesis of
low-tension glaucoma, International Opthalmology 1989;12:281-90.
Schoenberg M.J., The artificial induction of ocular hypertension
by compression of the jugular veins, Archives of Opthalmology 1929;
1:681-91.
Hayashi H. Welcome to Microwater! Tokyo, Japan: Water Institute.
Whang S. Reverse Aging. Englewood Cliffs, New Jersey: Siloam Enterprises,
Inc., 1994.
Terrain measurement of water, blood, urine, saliva may be made with
BTA (Biological Terrain Assessment) instrumentation available through
Starfire International’s professional division.
Shapiro A., The physiological changes that may affect intraocular
pressure, Investigative Opthalmology 1983, pp 895.
Ashworth B., Chronic demyelinationg optic neuritis, Neuro-opthalmology1987;7:75-79.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Stocker F.W., New ways of influencing the intraocular pressure,
New York State Medical Journal 1949;49:58-63.
Stocker F.W., Holt L.B., Clower J.W., Clinical experiments iwth
new ways of influencing intraocular tension, Archives of Opthalmology
1949;40:46-55.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Evans S.C., Opthalmic nutrition and prevention of eye disorder and
blindness, Nutrition Metabolism 1977; 21: 268-72 Supplement.
Todd GP. Nutrition, Health & Disease. (Norfolk, Virginia: Donning
Co. Pub., 1985) p. 17.
Krishna S.M., Shukla P.K, Vitamin A and primary glaucoma, Glaucoma
1982; 4: 226-27.
Schweitzer D., et al, Spectrometric investigationsin ocular hypertension
and early stages of primary open angle glaucoma and of low tension
glaucoma - multisubstance analysis, International Opthalmology 1992;
16:251-57.
May BM. personal communication.
Voelker R., Recommendations for antioxidants: how much evidence
is enough? Journal American Medical Assn., 1994; 271: 1145-56.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Altura B.M., Altura B.T., Cardiovascular risk factors and magnesium,
Magnesium Trace Elements 1991;10;182-92.
Asregadoo ER. Annals of Ophthalmology, July, 1979.
Asregadoo E.R., Blood levels of thiamine and ascorbic acid in chronic
open-angle galucoma, Annals of Opthalmology 1979;11:1095-1100.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Lucidi EA. Glaucoma: Nutrition and healthy living can help! The
Holistic Optometrist 5:2-3, Jan/Feb, 1987.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Lucidi EA. Glaucoma: Nutrition and healthy living can help! The
Holistic Optometrist 5:2-3, Jan/Feb, 1987.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 49.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Quamme G.A., et al, Dynamics of intracellular free Mg2+ changes
in a vascular smooth muscle cell line, American Journal of Physiology
1993; 265:H281-H288.
SerVaas C., The Post investigates B12 deficiency, The Staruday Evening
pOst, July-August 1994, pp.48-50 & 60.
Agamanolis P., et al, Neuropathology of experimental vitamin B12
defeciency in monkeys, Neurology 1976; 26:905-14.
Gruener D.M., et al, Dietary vitamin B12 deficiency in patients
with multiple sclerosis, General Hospital Psychiatry 1994; 16:224-28.
Reynolds E.H., Linnell J.C., Faludy J.E., Multiple sclerosis associated
with vitamin B12 deficiency, Archives of Neruology 1991;48:808-11.
Wilhelm J., Grodd B., German Journal of Opthalmology 1993; 2:234-40.
Metz J., Pathogenesis of cobalamin neuropathy: deficiency of nervous
system S-adenomethionine?, Nutrition Reviews 1993;51:12-15.
Psychiatric and neurologic manifestations of vitamin B12 deficiency,
Journal of Geriatric Psychiatry and Neurology 1990; 3:114-15.
Caroll F.D., The etiology and treatment of tobacco-alcohol amblyopia,
American Journal of Opthalmology 1944;27:713-25.
Cohen H., Optic atrophy as the presenting sign in pernicious anemia,
The Lancet 1936; November 21, p. 1202-03.
Bidlack W.R., Nutritional requirements of the elderly, in Geriatric
Nutrition, John E. Morley, editor, Raven Press, 1990, 49-72.
Bell I.R., et al, Relationship of normal serum vitamin B12 and floate
levels to cognitive test performance in subtypes of geriatric major
depression, Journal of Feriatric Psychiatry and Neurology 1990;
3: 98-104.
Roseman R., Ellenberger C. Jr., Slowly progressive optic neuritis,
Neuro-opthalmology 1982; 2:183-94.
Sakai T., Murata M., Amemiya T., Effect of long-term treatment of
glaucoma with vitamin B12, Glaucoma 1992; 14:167-70.
Wirell M.P. Wester P.O., Stegmayr B.G., Nutritional doses of magnesium
in hypertensive patients on beta blockers lowers systolic blood
pressure: a double-blind, cross-over study, Journal of Internal
Medicine 1994; 236:189-95.
Seelig M.S., Magnesium, antioxidants and myocardial infarction,
Journal American College of Nutrition 1994; 13:116-17; Merrill J.J.,
et al, Magnesium reversal of digoxin-facilitated ventricular rate
during atrial fibrillation in the Wolff-Parkinson-White syndrome,
The American Journal of Medicine 1994; 97:25-28; Singh R.B., Effect
of dietary magnesium supplementation in the prevention of coronary
heart disease and sudden cardiac death, Magnesium Trace Elements
1990; 9: 143-51; Leppert J., et al, Effect of magnesium sulfate
infusion on circulating levels of noradrenaline, Angiology 1994;
45:637-45.
Cohen L., Laor a., Kitzes R., Reversible retinal vasospasm in magnesium-treated
hypertension despite no significant change in blood pressure, Magnesium1984;
3:159-63.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Foulds W.S., et al, Archives of Opthalmology 1969;82:427-32.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Lucidi EA. Glaucoma: Nutrition and healthy living can help! The
Holistic Optometrist 5:2-3, Jan/Feb, 1987.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Kavner RS, and Dusky L. Total Vision. (New York: A&W Visual
Library, 1978) p.146-7.
Virno M, et al. Oral treatment of glaucoma with vitamin C. Eye,
Ear, Nose, & Throat Monthly 46:1502-8, 1967.
Lane BC. Elevation of intraocular pressure with daily, sustained
closework stimulus to accomodation to lowered tissue chromium and
dietary deficiency of ascorbic acid (vitamin C). Ph.D. dissertation,
1980, New York University.
Linner E. The pressure lowering effects of ascorbic acid in ocular
hypertension. Acta Ophthalmologica (Copenhagen) 47:685-9, 1969.
Linner E. Intraocular pressure regulation and ascorbic acid. Acta
Soc. Med. Upsal. 69:225-32, 1964.
Baxter RC. Vitamin C and glaucoma. Journal of the American Optometric
Association 59:438, June, 1988.
Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Vol. I.
Seattle: John Bastyr College Publications, 1987.
Higginbotham E., et al, Effects of ascorbic acid on trabecular meshwork
cells in culture, Experimental Eye Research 1988;46:507-16; Chang
S., et al, Effects of ascorbic acid on the production of fibronectin,
laminin and collagen type I by bovine trabecular meshwork cells
in organ culture, Investigative Opthalmology 1995; 35: arvo Abstracts.
Virno M., et al, “Aqueous humor alkalosis and marked reduction
in ocular ascorbic acid content following long-term topical cortisone,”
Annals of Opthalmology, 1974; 6:983-92.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Stocker FW. New ways of influencing intraocular pressure. New York
State Journal of Medicine 49:58-63, 1949.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Vol. I.
Seattle: John Bastyr College Publications, 1987.
Stocker F.W., Clinical experiments with new ways of influencing
the intraocular pressure. 1949; 41: 429-35.
Amellal M., et al, Inhibition of mast cell histamine release by
flavonoids and biflavnoids, Planta Medica 1985; 16-20.
Duarte J., Vasodilator effects of quercetin in isolated rat vascular
smooth muscle, European Journal of Pharmacology 1993; 239:1-7.
Morel I., et al, Antioxidant and iron-chelating activities of the
flavonoids catechin, quercetin and diosmetin on iron-loaded rat
hepatocyte cultures, Biochemical Pharmacology 1993; 45: 13-19.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 58.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 49.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Schumer R.A., Podos S.M., The nerve of glaucoma, Archives of Opthalmology
1994; 112:37-44.
Evans S.C., Opthalmic nutrition and prevention of eye disorder and
blindness, Nutrition Metabolism 1977; 21:268-72 Supplement.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
University of California at Berkely Wellness Letter, 1994; 10:1-4.
Langsjoen P., Vadhanavikit S., Folkers K., Response of patients
in classes III and IV of cardiomyopathy to therapy in a blind crossover
trial with coenzyme Q10, Proceedings of the National Academy of
Sciences, 1985; 82:4240-44.
Merati G., et al, Antioxidant activity of ubiquinone-3 in human
low density lipoprotein, Free Radical Research Communications 1992;
16:11-17.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Filina AA, Davydova NG, Endrikhovskii SN, et al. Lipoic acid as
a means of metabolic therapy of open-angle glaucoma. Vestn Oftalmol
1995;111:6–8.
Seely S., Is calcium excess in Western diet a major cause of arterial
disease?, International Journal of Cardiology 1991; 33:191-98.
Lane BC. Elevation of intraocular pressure with daily, sustained
closework stimulus to accomodation to lowered tissue chromium and
dietary deficiency of ascorbic acid (vitamin C). Ph.D. dissertation,
1980, New York University.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Kutsky RJ. Handbook of Vitamins, Minerals and Hormones. (New York:
Van Nostrand Reinhold, 1981) 113-23.
Becker B. Proctor Lecture. Investigative Ophthalmology and Vision
Science 19(10):1156-65, 1980.
Lane BC. Journal of the International Academy of Preventive Medicine
7(3=Nov):17-30, 1982.
Abraham A.S., et al, The action of chromium on serum lipids and
on atherosclerosis in cholesterol-fed rabbits, Atherosclerosis 1982;
42:185-95.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Safran A.B., et al, Topical timolol maleate might adversely affect
serum lipoproteins, International Opthalmology 1993; 17:109-10.
Roeback J.R., et al, Effects of chromium supplementation on serum
high-density lipoprotein cholesterol levels in men taking beta-blockers,
Annals of Internal Medicine 1991; 115:917-24.
Young S.G., Parthasarathy S., Why are low-density lipoproteins atherogenic?
Western Journal of Medicine 1994; 160: 153-64.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Young S.G., Parthasarathy S., Why are low-density lipoproteins atherogenic?
Western Journal of Medicine 1994; 160: 153-64.
Netland PA of Massachusetts Eye and Ear Infirmary quoted in: Top
researchers compare notes on eye disease. Review of Optometry, November
15, 1995. p. 8.
Netland P.A., et al, Calcium channel blockers in the management
of low-tension and open-anlge glaucoma, 1993; 115:608-13.
Gaspar A.Z., Gasser P., Glammer J., The influence of magnesium on
visual field and peripheral vasospasm in glaucoma, Opthalmologica
1995; 209:11-13.
Henahan R., Nifedipine helpful in treating low-tension glaucoma,
Ocular Surgery News 1992; March 1, p.79.
Abelson M.B., Gilbert C.M., Smith L.M., Sustained reduction of intraocular
pressure in humans with the calcium channel blocker Berapamil, American
Journal of Opthalmology 1988; 105: 155-59.
McLean R.M., Magnesium and its therapeutic uses: a review, The American
Journal of Medicine 1994; 96:63-76.
Willis A.L., CRC Handbook of Eicosanoids: Prostaglandins and related
lipids, Volume I, Part A, CRC Press, Boca Raton, 1987, pp.31.
Bauscher L.P. Horio B., Regulation of cyclic AMP production in adult
human ciliary processes, Experimental Eye Research 1993; 60:43-48.
Altura B.M., Altura B.T., Cardiovascular risk factors and magnesium,
Magnesium Trace Elements 1991; 10: 182-92.
National Center for Health Statistics, Centers for Disease Control,
Dietary intake of vitamins, minerals and fiber of person age 2 months
and over in the United States: Third National Health and Nutriiton
Examination Survey, Phase 1, 1988-91, Number 258, November 14, 1994.
Quamme G.A., et al, Dynamics of intracellular free Mg2+ changes
in a vascular smooth muscle cell line, American Journal of Physiology
1993; 265: H281-H288.
Wirell M.P. Wester P.O., Stegmayr B.G., Nutritional doses of magnesium
in hypertensive patients on beta blockers lowers systolic blood
pressure: a double-blind, cross-over study, Journal of Internal
Medicine 1994; 236:189-95.
246 Cohen L., Laor A., Kitzes R., Reversible retinal vasospasm in
magnesium-treated hypertension despite no significant changes in
blood pressure, Magnesium 1984; 3: 159-63.
Gaspar A.Z., Gasser P., Glammer J., The influence of magnesium on
visual field and peripheral vasospasm in glaucoma, Opthalmologica
1995; 209:11-13.
Merrill J.J., et al, Magnesium reversal of digoxin-facilitated ventricular
rate during atrial fibrillation in the Wolff-Parkinson-White syndrome,
The American Journal of Medicine 1994; 97:25-28.
Singh R.B., Effect of dietary magnesium supplementation in the prevention
of coronary heart disease and sudden cardiac death, Magnesium Trace
Elements 1990.
Seelig M.S., Magnesium, antioxidants and myocardial infarction,
Journal American College of Nutrition 1994; 13:116-17.
Leppert J., et al, Effect of magnesium sulfate infusion on circulating
levels of noradrenaline, Angiology 1994; 45:637-45.
Seelig M.S., Consequences of magnesium deficiency on the enhancement
of stress reactions; prevetive and therapeutic implications, Journal
of the American College of Nutrition, 1994; 13:429-46.
National Center for Health Statistics, Centers for Disease Control,
Dietary intake of vitamins, minerals and fiber of person age 2 months
and over in the United States: Third National Health and Nutriiton
Examination Survey, Phase 1, 1988-91, Number 258, November 14, 1994.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 54.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 42.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 42.
May BM. personal communication.
Zinc sulfate solution and instructions for testing are available
from Remission Foundation.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Raymond LF. Allergy and chronic simple glaucoma. Annals of Allergy
22:146-50, 1964.
Berens C, et al. Allergy in glaucoma. Manifestations of allergy
in three glaucoma patients as determined by the pulse-diet method
of Coca. Annals of Allergy 5:526-35, 1947.
Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Vol. I.
Seattle: John Bastyr College Publications, 1987.
Sjogren H., Allergically conditioned changes in the intraocular
pressure, Acta Opthalmologica 1938; 16:542-47.
Berens C., Girard L.J. Cummings E., Allergy in glaucoma, Annals
of Allergy 1947; 5: 526-35.
Raymond L.F. Allergy and chronic simple glaucoma, Annals of Allergy,
1964; 22:146-50.
Raymond L.F. Allergy and chronic simple glaucoma, Annals of Allergy,
1964; 22:146-50.
WoldeMussie E., Ruiz G., Effect of histamine on signal transductionin
cultured human trabecular meshwork, Current Eye Research 1992; 11:987-93.
SerVaas C, The Post Investigates B12Deficiency, The Saturday Evening
Post, July-August 1994, pp.48-50 & 60.
Kumar R., et al, Histocompatibility antigens in Indian patients
with congenital glaucoma, Glaucoma 1991; 13:171-73.
May BM, personal communication.
Dreyer BA of Massachusetts Eye and Ear Infirmary quoted in: Top
researchers compare notes on eye disease. Review of Optometry, November
15, 1995. p. 8.
Ames B, Proceedings of the National Academy of Sciences of the USA
(Nov. 8,
1994;91:10771-8)
Sardi B. Glaucoma: Underlying Factors, Part 3. Townsend Letter for
Doctors & Patients, Jan. 1996, 52-65.
Schnohr P., et al, Eff consumptions and high-density-lipoprotein
cholesterol, Journal of Internal Medicine 1994; 235:249-51.
Stocker F.W., New ways of influencing the intraocular pressure,
New York State Medical Journal 1949; 49:58-63.
Stocker F.W., Holt L.B., Clower J.W., Clinical experiments iwth
new ways of influencing intraocular tension, Archives of Opthalmology
1949;40:46-55.
Sardi B. Glaucoma: Underlying Factors, Part 3. Townsend Letter for
Doctors & Patients, Jan. 1996, 52-65.
Seddon J.M., Dietary carotenoids, vitamins A, C and E, and advaced
age-related macular degeneration, Journal American Medical Association,
1994:272:1413-20.
Seddon J.M., Dietary carotenoids, vitamins A, C and E, and advaced
age-related macular degeneration, Journal American Medical Association,
1994:272:1413-20.
Werback MR, and Murray MT. Botanical Influences on Illness. (Tarzana,
California: Third Line Press, 1994).
The Curious Case of Coleus, Mediherb Professional Newsletter, 1990:
9 & 12.
Meyer BH, et al. The effects of forskolin eye drops on intraocular
pressure. South African Medical Journal 71(9):570-1, 1987.
Seto C, et al. Acute effects of topical forskolin on aqueous humor
dynamics in man. Japanese Journal of Ophthalmology 30:238-44, 1986.
Caprioli J, Sears M. Forskolin lowers intraocular pressure in rabbits,
monkeys, and man. Lancet i:958-60, 1983.
Burnstein N.L., Sears M.L., Mead A., Aqueous flow in human eyes
is reduced by forskolin, a potent adenylae cyclase activator, Experimental
Eye Research 1984; 39:745-49.
Kreutner W., Chapman R.W., et al, Bronchodilation and antiallergy
activity of forskolin, European Journal of Pharmacology 1985; 111:1-8.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 54.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 56.
The Curious Case of Coleus, Mediherb Professional Newsletter, 1990:
9 & 12
The Curious Case of Coleus, Mediherb Professional Newsletter, 1990:
9 & 12
Shibata T., et al, Ocular pigmentation and intraocular pressure
response to forskolin, Current Eye Research 1988; 7:667-74.
Murphy M.G., Bycko Z., Non-eicosanoid functions of essential fatty
acids: regulation of adensoine-related functions in cultured neuroblastoma
cells, Neurobiology of Essential Fatty Acids, NG Bazan, editor,
Plenum Press, New York, 1992, pp. 91-102.
Merte HJ, Merkle W. Long-term treatment with Ginkgo biloba extract
of circulatory disturbances of the retina and optic nerve. J Klin
Monatsbl Augenheilkd 177(5):577-83, 1980.
Schumer R.A., Podos S.M., The nerve of glaucoma, Archives of Opthalmology1994;112:37-44.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Zhen-zhong W, et al. Radix Salviae Miltiorrhizae in middle and late
stage glaucoma. Chinese Medical Journal 96(6):445-7, 1983.
Cooler P., Gregg J.M., Effect of delta-9-tetrahydrocannabinol on
intraocular pressure in humans, S outhern Medical Journal 1977;
70:951-54.
Cooler P., Gregg J.M., Effect of delta-9-tetrahydrocannabinol on
intraocular pressure in humans, S outhern Medical Journal 1977;
70:951-54.
Goldberg I., Kass M.A., Becker B., Marijuana as a treatment for
glaucoma, The Sightsaving Review, Winter 1978-79, 147-155.
Zimmerman T.J., Marijuana in opthalmology - past, present and future,
Annals of Opthalmology 1979;203-05.
U.S. Rescinds approval of marijuana as therapy, The New York Times
March 11, 1992.
Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Vol. I.
Seattle: John Bastyr College Publications, 1987.
Bever B, Zahnd G. Plants with oral hypoglycemic action. Quart J
Crude Drug Res 17:139-96, 1979.
Gabor M. Pharmacological effects of flavonoids on blood vessels.
Angiologica 9:355-74, 1972.
Monboisse J, et al. Oxygen-free radicals as mediators of collagen
breakage. Agents Actions 15:49-50, 1984.
Hagerman A, Butler L. The specificity of proanthocyanidin-protein
interactions. J Biol Chem 256:4494-7, 1981.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Nakanome Y., et al, Two types of vasodilation in cat choroid elicited
by electrical stimulation of short ciliary nerve, Experimental Eye
Research 1995; 60:37-42.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 117.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 49.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 117-118.
Yamazaki Y. Lost vision rapidly restored; Continuous improvement
in cases of cataracts, glaucoma, etc. (published as Chapter 6 in
The Secrets of Spirulina).
Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Vol. I.
Seattle: John Bastyr College Publications, 1987.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 190-1.
Josephson. Glaucoma and cortin. Chedney Press, 1937.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Samples J.R., Krause G., Lewy A.J., Effect of melatonin on intraocular
pressure, Current Eye Research 1988; 7:649-78.
Schoenberg M.J., Role of state of anxiety in the pathogenesis or
primary glaucoma, Archives of Opthalmology 1960; 49:297-305.
Reiter R.J., et al. Melatonin Suppression by Static and Extremely
Low Frequency Electromagnetic Fields: A Relationship to the Reported
Increased Incidence of Cancer, Reviews in Environmental Health,
1994;10(3-4):171-186.
Violet and Red filters are available from Remission Foundation for
$2 each. Color therapy glasses or clip-ons in the appropriate colors
are also available for $18 each.
Reiss G.R., et al, Aqueous humor flow during sleep, Investigative
Opthalmology Visual Science 1984; 25:776-78.
Wilensky J.T., Zeimer R.C., Gieser D.K., Rapid decline of early
morning intraocualar pressure peaks, Investigative Opthalmology
1989; 30: Arvo Abstracts 65.
Viggiano S.R., et al, The effect of melatonin on aqueous humor flow
in humans during the dayu, Opthalmology 1994; 101:326-31.
Sardi B. Glaucoma: Underlying Factors, Part 2. Townsend Letter for
Doctors & Patients, Dec. 1995, 46-51.
Lucidi EA. Glaucoma: Nutrition and healthy living can help! The
Holistic Optometrist 5:2-3, Jan/Feb 1987.
Weitzman E.D., Henkind P., Leitman M., Hellman L., Correlative 24-hour
relationships between intraocular pressure and plasma cortisol in
normal subjects and patients with glaucoma, British Journal Opthalmology
1975; 59: 566-72.
Martin X.D., Licheter P.R., Neuropharmacologic control of intraocular
pressure, Perspectives in Glaucoma, M.Bruce Shields, et al, editors,
Slack Inc., Thorofare, NJ, 1988.pp.113-23.
Haefliger I.O., et al, The vascular endothelium as a regulator of
the ocular circulation: a new concept in opthalmology?, Survey of
Opthalmology 1994; 39: 123-32.
Mayhan W.G., Rubinstein I., Acetycholine induces vasoconstriciton
in the microcirculation of cardiomyopathic hamsters: revesal by
L-arginine, Biochemical and Biophysical Research Communications
1992; 184: 1372-77.
Cestaro B., Effects of arginine, S-adenosylmethionine and polyamines
on nerve regeneration, Acta-Neurology Scandanavia Supplement 1994;
154: 32-41.
Kahn M.G., Giblin F.J., Epstein D.L., Glutathione in claf trabecular
meshwork and its relation to aqueous humor outflow facility, Investigative
Opthalmology 1983; 24: 1283-87.
Flores F.P., Multiple causes of flaucoma: a role for oxygen free
radicals, Chibret International Journal of Opthalmology 1994; 10:
24-27.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Freddo TF. Study hints at complexities of aqueous outflow. American
Optometric Association News (reporting on study published in Optometry
and Vision Science, April issue).
Russell P., Koretz J., Epstein D.L., Is primary open angle glaucoma
caused by small proteins?, Medical Hypotheses 1993; 41:455-58.
Inada K., et al, Increase of aqueous humor proteins with aging,
Japanese Journal of Opthalmology 1988; 32: 126-31.
Balch JF, Balch PA. Prescription for Nutritional Healing. (New York:
Avery, 1990) 32-36.
Guy J., et al, Reversals of blood-brain barrier disruption by catalase:
a serial magnetic resonance imaging study of experimental
Veriac S., Tissie G., Bonne C., Alterations of energetic metabolite
levels by free radicals during optic nerve ischemia, Current Eye
Research 1992; 11: 275-78.
Guy J., Elliw A., Hope G.M., Rao N., Antioxidant enzymes reduce
loss of blood-brain barrier integrity in experimental optic neuritis,
Archives of Opthalmology 1989; 107: 1359-63.
Sever P.S., et al, Blood pressure and its correlates in urban and
tribal Africa, Tha Lancet, 1980; July 12, 60-64.
Shmid RF. Native Nutrition. Rochester, Vermont: Healing Arts Press,
1987.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Higginbotham E., et al, Effects of ascorbic acid on trabecular meshwork
cells in culture, Experimental Eye Research 1988;46:507-16; Chang
S., et al, Effects of ascorbic acid on the production of fibronectin,
laminin and collagen type I by bovine trabecular meshwork cells
in organ culture, Investigative Opthalmology 1995; 35: Arvo Abstracts.
Mayhan W.G., Rubinstein I., Acetycholine induces vasoconstricitoni
the microcirculation of cardiomyopathic hamsters: reversal by L-arginine,
Biochemical and Biophysical Research Communications 1992; 184: 1372-77.
Woodbury M.M., Woodbury M.A., A case report: Raynaud’s disease
improvements with dietary fish oil supplements in a young child,
American College of Nutrition 1992; 11: 635 Poster Session Abstract
126.
DiGiacomo R.A., Kremer J.M., Shah D.M., Fish oil dietary supplementation
in patients with Raynaud’s phenomenon: a double-blind, controlled,
prospective study, American Journal of Medicine 1989; 86: 158-64.
Bito LZ. Glaucoma: Applied Pharmacology in Medical Treatment. Grune
& Stratton, 1984.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Mancio M., Ohia E., Kulkarni P., A comparative study between cold
liver oil and liquid lard intake on intraocular pressure on rabbits,
Prostaglandins Leukotrienes and Essential Fatty Acids, 1992; 45:
239-43.
McLean R.M., Magnesium and its terapeutic uses: a review, The American
Journal of Medicine 1994; 96: 63-76.
Willis A.L., CRC Handbook of Eicosanoids: Prostaglandins and related
lipids, Volume I, Part A, CRC Press, Boca Raton, 1987, pp.31.
Jamel G.A., The use of gamma linolenic acid in the prevention and
treatment of diabetic neuropathy, Diabetic Medicine 1994; 11: 145-49.
Higginbotham E., et al, Effects of ascorbic acid on trabecular meshwork
cells in culture, Experimental Eye Research 1988;46:507-16; Chang
S., et al, Effects of ascorbic acid on the production of fibronectin,
laminin and collagen type I by bovine trabecular meshwork cells
in organ culture, Investigative Opthalmology 1995; 35: Arvo Abstracts.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 58.
Murphy M.G., Byczko Z., Non-eicosanoid functions of essential fatty
acids: regulation of adenosine-related functions in cultured neuroblastoma
cells, Neruobiology of Essential Fatty Acids, NG Bazan, editor,
Plenum Press, New York, 1992, pp. 91-102.
Sardi B. Glaucoma: Anti-Glaucoma Regimen Emphasizing Non-Pharmacologic
Therapy and Lifestyle Changes, Part 3 of a 3-Part Series. Townsend
Letter for Doctors & Patients, Jan. 1996; 63.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 49.
Norton AB. Ophthalmic Diseases and Therapeutics. (New Delhi: Jain,
1987) 480-482.
Moffat JL. Homeopathic Therapeutics in Ophthalmology. (New Delhi:
Jain, 1982) 129-130.
Stone EM. Glaucoma gene mapped by researchers. Review of Optometry,
p 10, August 1993.
Nosode Therapy in Practice. Baden-Baden, Germany: Biologische Heilmittel
Heel GmbH, 1985; p. 22.
Moffat JL. Homeopathic Therapeutics in Ophthalmology. New Delhi,
India: B. Jain Publishers, 1982; p. 132.
Moffat JL. Homeopathic Therapeutics in Ophthalmology. New Delhi,
India: B. Jain Publishers, 1982; p. 132.
Voll R. 2nd Supplement to the Four Volume Work Topographical Positions
of the Measurement Points of Electroacupuncture According to Voll,
EAV Diagnosis of Eye Disease, 15 New Measurement Points for Portions
of the Eye, EAV Therapy for Eye Diseases, 5 New Approaches. Uelzen,
Germany: Medizinisch Literarische Verlagsgesellschaft MBH, 1983.
For information regarding non-toxic UV tinting of eyeglass lenses
without distortion of the visible spectrum, or regarding UV protective
contact lenses, call Remission Foundation at 800-788-2442.
Ringbold A., et al, The middle-Norway eye-screening study, Acta
Opthalmologica 1988; 66: 652-58.
Schlotzer-Schrehardt U., et al, Pseudoexfolative material in the
eyelid skin of pseudoexfoliation-suspect patients: a clinico-histopathological
correlation, German Journal of Opthalmology 1993; 2: 51-60.
O’brien J.P., Solar and radiant damage to elastic tissue as
a cause of internal vascular disease, Australian Journal Dermatology
1980; 21: 1-9.
Hightower K.R., et al, Lens epithelium: a primary target of UVB
irradiation, Experimental Eye Research 1994; 59: 557-64.
Zigman S., et al, Mechanisms of lens epithelial cell cytotoxicity
form near UV exposure and protection by antioxidants, Investigative
Opthalmology 1993; 34 Arvo Abstracts 2935.
Zaretskaya RB. American Journal of Ophthalmology 31:721-7 and 985-9,
1948. (note: color therapy glasses and clip-ons are available from
Remission Foundation)
Spitler HR. The Syntonic Principle. (College of Syntonic Optometry,
1941) p. 203.
Kaplan R. Changes in Form Visual Fields in Reading Disabled Children
Produced by Syntonic Stimulation. International Journal of Biosocial
Research, 1983; 5(1): 20-33.
Liberman J. The Effect of Syntonic Colored Light Stimulation on
Certain Visual and Cognitive Functions. Journal of Optometric Vision
Development, June 1986; 17
10.5% of beta blocker users break hips compared to 3.3% of non-users.
Reported in Sardi B. Glaucoma - Part 1. Is the treatment worse than
the disease? Townsend Letter for Doctors and Patients 148: 64-68,
1995.
Dinshah D. Let There Be Light, (Malaga, New Jersey: Dinshah Health
Society, 1985) p. 65.
Omura U., Non-invasive circulatory evaluation and electro-acupuncture
and TES treatment of disease difficult to treat in western medicine,
Acupuncture & electo-Therapeutics Research International Journal
1983; 8: 177-255.
Rohde B.H., Li B.H.P., Chiou C.Y., Effects of melatonin and haloperidol
given via vortex vein on the intraocular pressure, Opthalmic Resarch
1993; 25: 10-15.
Qiping W., Treatment of optic nerve atrophy with acupuncture, Journal
of Traditional Chinese Medicine 1992; 12: 142-46.
Shuhan G., Benren X., 38 cases of optic atrophy treatment by needling
qiuhou point, Journal of Traditional Chinese Medicine 1989; 9: 171-72.
Ralston N.C., Successful treatment and management of acute glaucoma
using acupuncture, American Jouranl of Acupuncture 1977; 5: 283.
Cohen SI, Hajoff J. Life events and the onset of acute closed-angle
glaucoma. Journal of Psychosomatic Research 16:355-41, 1972.
Duke-Elder W.S., Textbook of Opthalmology, C.B. Mosby Co, St. Louis,
Vol.I, 1948.
Croll M.C., Croll L.J., Emotional glaucoma, American Journal of
Opthalmology 1960; 49: 297-305.
Grignolo FM, et al. Variations of intraocular pressure induced by
psychological stress (Abstract). Klin Monatsbl Augenheilkd 170:562-9,
1977.
Stocker F.W., Holt L.B., Clower J.W., Clinical experiments with
new ways of influencing intraocular tension, Archives of Opthalmology
1948; 40: 46-55.
Ripley HS, Wolff HG. Life situation, emotions and glaucoma. Psychosomatic
Medicine 12:215-24, 1948.
Schoenberg M.J., Role of state of anxiety in the pathogenesis or
primary glaucoma, Archives of Opthalmology 1940; 23: 76-90.
Bloom E., Effects of oxidative injury on phagocytosis in human trabecular
meshwork (HTM) cells, Investigative Opthalmology 1990; 31: Arvo
Abstracts March 15.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.19.
Ripley H.S., Wolff H.G., Life situations, emotions and glaucoma,
Psychosomatic Medicine 1950: 12: 215-24.
Rotberg M.H., Biofeedback for opthalmologic disorders, Survey of
Opthalmology 1983; 27: 381-86.
Passo M.S., et al, Exercise training reduces intraocular pressure
among subjects suspected of having glaucoma, Archives of Opthalmology
1991; 109: 1096-98.
Martin B.J., et al, Ocular hypotension after exercise, Investigative
1994; 35: 191-95.
Krishna S.M., Shukla P.K., Vitamin A and primary glaucoma, Glaucoma
1982; 4: 226-27.
Passo M.S., et al, Exercise training reduces intraocular pressure
among subjects suspected of having glaucoma, Archives of Opthalmology
1991; 109: 1096-98.
Kiuchi Y., et al, Exercise intensity determines the magnitude of
IOP decrease after running, Japanese Journal of Opthalmology 1994;
38: 191-95
Harris A., et al, Vasospasm in normal tension glaucoma: color doppler
imagin assessment of carbon dioxide reactivity in orbital vessels,
Investigative Opthalmolgy 1994; 35: Arvo Abstracts March 15.
Cooper KH, et al. Aerospace Medicine 36:51-53, 1965.
Sardi B. Glaucoma: Underlying Factors, Part 3. Townsend Letter for
Doctors & Patients, Jan. 1996, 52-65.
Sardi B. Nutrition and the Eyes, Vol. III. Montclair, California:
HealthSpectrum Publishers, 1994, p. 50.
Passo M.S., et al, Regular exercise lowers intraocular pressure
in glaucoma patients, Investicative Opthalmology 1994; 35: Arvo
Abstracts March 15.
Blumenthal M., Blumenthal R., Peritz E., et al, Seasonal variation
in intraocular pressure, American Journal of Opthalmology 1970;
69: 608-10.
Haefliger I.O., Meyer P., Glammer J., Luscher T.F., The vascular
endothelium as a regulator of the ocular circulation: a new concept
in opthalmology? Survey of Opthalmology 1994; 39:123-32.
Haynes W.L., Johnson A.T., Alward W.L.M., Effects of jogging exercise
on patients with the pigmentary dispersion syndrome and pigmentary
glaucoma, Opthalmology 1992; 99: 1096-1103.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.20.
Rice R., Allen R.C., Yoga in glaucoma, American Journal of Opthalmology
1970; 69: 608-10.
Leonard T.J.K., Kerr-Muir M.G., Kirkby G.R., Ocular hypertension
and posture, British Journal of Opthalmology 1983; 67: 1673-76.
Weinreb R.N., Effect of inverted body position on intracular pressure,
American Journal of Opthalmology 1984l 98L 784-87.
Martin X.D., Lichter P.R., Neuropharmacologic control of intraocular
pressure, Perspectives in Glaucoma, M.. Bruce Shields, et al, editors,
Slack Inc., Thorofare, NJ, 1988. pp. 113-23.
Sardi B. Glaucoma: Underlying Factors, Part 3. Townsend Letter for
Doctors & Patients, Jan. 1996, 52-65.
Swartwout JB. personal communication.
Moses R.A., Preston L., Wette R., Horizontal gaxe postion effect
on intraocular pressure, Investigative Opthalmology 1982; 22: 551-53.
Shibata T., et al, Ocualr pigmentationa dn intraocular pressure
response to forskolin, Current Eye Research 1998; 7: 667-74.
Norton AB. Ophthalmic Diseases and Therapeutics. (New Delhi: Jain
Publishers, reprinted 1987) p. 480.
Swartwout GM. Eye Points. Hilo, Hawaii: Remission Foundation, 1995.
Swartwout GM. Palming. Hilo, Hawaii: Remission Foundation, 1995.
Swartwout GM. Eye Stretch. Hilo, Hawaii: Remission Foundation, 1995.
Lane BC. Elevation of intraocular pressure with daily, sustained
closework stimulus to accomodation to lowered tissue chromium and
dietary deficiency of ascorbic acid (vitamin C). Ph.D. dissertation,
1980, New York University.
Herbs available through Remission Foundation, 800-788-2442.
Lane BC. Interaction of diet, environment & activities on the
glaucomas. Presented at College of Syntonic Optometry, May 6, 1995.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.18.
Bidlack W.R., Nutritional requirements of the elderly, in Geriatric
Nutrition, John E. Morley, editor, Raven Press, 1990, 49-72.
Langan L.M., Watkins S.M., Pressue of menswear on the neck in relation
to visual performace, Human Factors 1987; 29: 67-71.
Sardi B. Nutrition and the Eyes, Vol. III., Montclair, California:
Health Spectrum Publishers, 1994, p.21.
|
